Importance of bone turnover for therapeutic decisions in patients with CKD-MBD
Open Access
- 1 September 2021
- journal article
- editorial
- Published by Elsevier BV in Kidney International
- Vol. 100 (3), 502-505
- https://doi.org/10.1016/j.kint.2021.05.024
Abstract
No abstract availableThis publication has 20 references indexed in Scilit:
- Effects of Cinacalcet on Fracture Events in Patients Receiving HemodialysisJournal of the American Society of Nephrology, 2015
- Hypocalcemia Post Denosumab in Patients with Chronic Kidney Disease Stage 4-5American Journal of Nephrology, 2015
- Incidence of atypical nontraumatic diaphyseal fractures of the femurJournal of Bone and Mineral Research, 2012
- Renal osteodystrophy in the first decade of the new millennium: Analysis of 630 bone biopsies in black and white patientsJournal of Bone and Mineral Research, 2010
- Effect of Alendronate on Vascular Calcification in CKD Stages 3 and 4: A Pilot Randomized Controlled TrialAmerican Journal of Kidney Diseases, 2010
- Effects of denosumab on bone histomorphometry: The FREEDOM and STAND studiesJournal of Bone and Mineral Research, 2010
- Association of Changes in Bone Remodeling and Coronary Calcification in Hemodialysis Patients: A Prospective StudyAmerican Journal of Kidney Diseases, 2008
- Pretreatment Levels of Bone Turnover and the Antifracture Efficacy of Alendronate: The Fracture Intervention TrialJournal of Bone and Mineral Research, 2006
- Arterial Calcifications and Bone Histomorphometry in End-Stage Renal DiseaseJournal of the American Society of Nephrology, 2004
- Is the paradigm shifting?Bone, 2003